RecruitingNot ApplicableNCT05362929
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
Sponsor
Albert Einstein College of Medicine
Enrollment
46 participants
Start Date
Oct 11, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing a hybrid fractional laser treatment for acne scars in people with darker skin tones (skin of color). Researchers want to see if this laser is both effective and safe, as some lasers can cause pigmentation changes in darker skin.
You may be eligible if...
- You are 18 years of age or older and in good general health
- You have diagnosed acne scarring (documented in the last 6 months)
- You are a non-smoker (no smoking or vaping in the past 12 months)
- You are willing to follow the treatment and follow-up schedule
- You agree not to undergo other acne scar treatments during the study period
You may NOT be eligible if...
- You have had acne scar treatments within the past 6 months
- You have active acne (papulopustular or cystic) within the past 6 months
- You have a history of keloid scarring
- You have had surgery in the treatment area within the past 12 months
- You have a history of immunosuppression, chemotherapy, or HIV/AIDS
- You have used Accutane (isotretinoin) or other systemic retinoids within the past year
- You have a history of photosensitivity, connective tissue disease, diabetes, hepatitis, bleeding disorders, or thyroid disorders
- You are currently pregnant or breastfeeding
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESciton Halo
Laser treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05362929
Related Trials
The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation
NCT070678791 location
AVAVA MIRIA General Use
NCT068686151 location
Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
NCT062534681 location
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
NCT062684961 location
Pilot Study of LED for PIE and PIH
NCT063494471 location